Greiner Bio-One webinars

Greiner Bio-One offers educational webinars for both BioScience and Preanalytics customers several times throughout the year at no charge to industry professionals. These webinars are recorded and made available to customers to enjoy in the future. 

Please note that recordings for Preanalytics webinars are available for a maximum of 7 days after the live event due to the requests of our speakers. When available, these recordings will be listed here. 

Magnetic 3D Cell Culture: Tools to Bridge the Gap Between 2D and 3D

The growing push for 3D cell culture models is limited by technical challenges in handling, processing, and scalability to high-throughput applications. To meet these challenges, Greiner Bio-One offers an innovative technology called  magnetic 3D bioprinting, in which cells are individually magnetized and assembled with magnetic forces without changing the phenotype or the physiology of these cells. Magnetization of cells not only makes routine cell culture and experiments feasible and scalable, but also enables scientist to have fine spatial control in the formation of spheroids or more complex structures.

This presentation will focus on recent developments using magnetic 3D bioprinting, particularly in cancer biology and immunology. Specifically, it will demonstrate a method for phenotypic profiling of cell types within spheroids using real-time high-throughput imaging.

 

Learning objectives:

  • General technique of magnetic 3D cell culture and magnetic 3D bioprinting
  • Key advantages of 3D cell culture over other techniques
  • Broad applications of 3D cell culture
  • Applications in immunobiology
  • Comparison between magnetic 3D cell culture and in vivo results in collaboration with MD Anderson Cancer Center

20. October 2020, 15:30, MEST

Presented by :
Glauco R. Souza, PhD Director of Global Business Developement and Innovation - Greiner Bio-One

Language :
English

Good Practice in Biobanking - A Labware Manufacturer's Perspective

More than ever we see an increasing demand for high-quality and high-throughput libraries of biological and chemical specimens. Reasons for this trend are diverse and range from ground-breaking developments in personalised medicine over new trends in compound screening to the enormously high throughput of patient samples in COVID-19 testing.
Learn about:

  • Good practices in sample storage and their link to labware
  • Types of storage containers and their intended applications
  • Options for sample tracking – how to utilise them optimally
  • Pre-requisites and prospects of process automation
  • Quality certificates for labware

16. October 2020, 11:00, BST

Presented by :
Sven Muehlfriedel - Greiner Bio-One Product Management

Language :
English

Cell Based Assay and Tissue Reconstruction in ThinCert Cell Culture Products

Ethical, scientific and financial concerns lead to an increasing importance of cell based assays and three-dimensional cell cultures in lieu of live-animal experimentation. With respect to these developments, ThinCert™ cell culture inserts with porous PET membranes are significant because they form a two-compartment system to readily mimic a variety of in vivo situations, such as:

1.  Cell migration and invasion,

2.  Interaction and communication of physically separated cell populations (co-culture)

3.  Trans-epithelial transport,

4.  Tissue growth and differentiation at the air-liquid-interface.

This presentation provides detailed insight in the different application fields of ThinCert™ cell culture inserts. Hints for the individual experimental design and the selection of the appropriate insert type are given.

22. March 2018, 11:00, Eastern

Presented by :
Sven Muhlfriedel Ph.D.

Language :
English

Preventing Specimen Rejection in the Collection of Non-Blood Samples

During the course of this 60 minute, P.A.C.E.® accredited webinar, attendees will achieve the following program objectives:

 

1. Identify best practices in collection of non-blood specimens.

2. Review situations resulting in rejection of non-blood specimens.

3. Explain the potential patient impact caused by inadequate specimen collection.

15. March 2018, 13:00, Eastern Daylight Time (New York, GMT-04:00)

Presented by :
Beth Warning

Language :
English